SCHEMBL26239658

SCHEMBL26239658

CCCCc1ccc(CC(=O)OCC)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
HPGD P15428 2/20 0.62
HSD17B10 Q99714 1/20 0.62
CYP4F2 P78329 2/20 0.53
CYP4A11 Q02928 2/20 0.53
CYP4Z1 Q86W10 2/20 0.51
MAPT P10636 2/20 0.49
RARB P10826 1/20 0.49
PLK1 P53350 1/20 0.49
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
AKT1 P31749 1/20 0.47
IRS1 P35568 1/20 0.47
GAB1 Q13480 1/20 0.47
PPARG P37231 1/20 0.47
PPARA Q07869 1/20 0.47
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CYP4F11 Q9HBI6 1/20 0.47
CYP4F12 Q9HCS2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15723417 0.95 ALDH1A1 (0.57) ALDH1A1HPGDHSD17B10CYP4F2CYP4A11
SCHEMBL7243687 0.93 ALDH1A1 (0.62) ALDH1A1HPGDHSD17B10CYP4F2CYP4A11
SCHEMBL9523313 0.93 ALDH1A1 (0.62) ALDH1A1HPGDHSD17B10CYP4F2CYP4A11
SCHEMBL15881008 0.93 ALDH1A1 (0.62) ALDH1A1HPGDHSD17B10CYP4F2CYP4A11
SCHEMBL10798505 0.89 CYP4F2 (0.56) ALDH1A1HPGDHSD17B10CYP4F2CYP4A11
SCHEMBL6057577 0.89 CYP4F2 (0.59) ALDH1A1HPGDHSD17B10CYP4F2CYP4A11
SCHEMBL68851 0.87 CYP4Z1 (0.62) ALDH1A1HSD17B10CYP4F2CYP4A11CYP4Z1
SCHEMBL6286441 0.86 CYP4F2 (0.72) ALDH1A1HPGDHSD17B10CYP4F2CYP4A11
Hydrochloric Acid SCHEMBL9259296 0.85 MAPT (0.49) ALDH1A1HPGDHSD17B10CYP4F2CYP4A11
SCHEMBL31502353 0.85 CYP4A11 (0.57) ALDH1A1HPGDHSD17B10CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024098361-A1 ARTIFICIAL NUCLEIC ACID MOLECULE 斯微(上海)生物科技股份有限公司 2024-05-16 WO disclosed
US-20230263742-A1 A LIPID Stemirna Therapeutics Co., Ltd. (CN) 2023-08-24 US disclosed
US-20230263742-A1 A LIPID Stemirna Therapeutics Co., Ltd. (CN) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263742-A1 A LIPID CETP, PLIN1, AUP1 ALDH1A1 1643/4885HPGD 3269/4885HSD17B10 949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.